Invention Grant
- Patent Title: Stabilizing excipient for inactivated whole virus vaccine
- Patent Title (中): 用于灭活全病毒疫苗的稳定赋形剂
-
Application No.: US14048144Application Date: 2013-10-08
-
Publication No.: US09028839B2Publication Date: 2015-05-12
- Inventor: Alain Francon , Michel Chevalier , Nadege Moreno , Eric Calvosa , Sandrine Cigarini , Virginie Fabre
- Applicant: Sanofi Pasteur
- Applicant Address: FR Lyons
- Assignee: Sanofi Pasteur S.A.
- Current Assignee: Sanofi Pasteur S.A.
- Current Assignee Address: FR Lyons
- Agency: McDonnell Boehnen Hulbert & Berghoff LLP
- Priority: FR0904795 20091007
- Main IPC: A61K39/205
- IPC: A61K39/205 ; A61K47/00 ; C12N7/02 ; A61K47/26 ; A61K39/12 ; A61K47/02 ; A61K47/10 ; A61K47/18 ; A61K39/00
Abstract:
The invention relates to a vaccine composition comprising:a) inactivated whole virus, andb) a stabilizing excipient which comprises: i. a buffer solution, ii. a mixture of essential and nonessential amino acids, iii. a disaccharide, iv. a polyol, v. a chelating agent, vi. urea or a urea derivative, and vii. a nonionic surfactant.
Public/Granted literature
- US20140037684A1 STABILIZING EXCIPIENT FOR INACTIVATED WHOLE VIRUS VACCINE Public/Granted day:2014-02-06
Information query
